What does it take for personalized cardiometabolic risk measurement?
Type 2 diabetes and heart disease remain the leading causes of reduced quality of life and reduced longevity.
#cardiometabolichealth
Posts by Precision Health Reports
Normal cholesterol ≠ no risk.
ApoB & Lp(a) can reveal hidden heart danger — but only if you see the whole picture.
Here’s how we combine them with guideline-based risk assessment to stop heart disease before it starts.
precisionhealthreports.com/apob-and-lpa...
We don't know who needs to hear this, but this is not an effective strategy to reduce your cardiometabolic disease risk.
Don't wait until your own 2-minute warning to find your heart attack and stroke risk.
#SuperBowlLIX
Time to intercept your risk factors for diabetes and heart disease.
Take control of YOUR health and know YOUR risk!
The Eagle's O-line clears the way for Jaylen Hurts for the Brotherly Shove first score of #SuperBowlLIX.
Doesn't your heart deserve the same support?🏈
In real life, there aren't any refs to overturn a heart disease pass interference call. (we're trying 🤣).
Only you can make the right call for your health!🫶
#SuperBowlLIX
If your team lets you down, at least your heart won’t—IF you take care of it!
Winning your Heart Health Super Bowl starts with understanding your personal risk for cardiometabolic disease.
Start now; link in first comment!
#SuperBowlLIX ❤️💚
Our Chief Medical Officer, Dr. Bill Cromwell, joined Joe Ence of VasoLabs to talk about noninvasive imaging, how ApoB gets stuck in your artery walls, and some thoughts on emerging tools available for ASCVD management.
youtu.be/oEquS6l_A_I?...
Excellent commentary from experts about the need for apoB testing by my friends at the NIH Division of Lipids/Lipoproteins/Vascular Biology: Ania Wolski and director Alan Remaley& one and only @dmljmd.bsky.social pubmed.ncbi.nlm.nih.gov/39899636/ @nationallipid.bsky.social @aspcardio.bsky.social
What do you know about GlycA? This fantastic newer biomarker is a better way to measure low-grade systemic inflammation than traditional hsCRP.
- stable single test
- does not have masking issues w/ statins
- much more precise (especially in women)
precisionhealthreports.com/high-glyca
Or you can get your Cardiometabolic Risk Assessment that quickly and accurately does steps 1-3 for you allowing you to focus on the important 4th step.
precisionhealthreports.com/order-assess...
3/3
1. Measure your ApoB.
2. Identify all of your other risk factors.
3. ID your goal.
4. Get your ApoB below goal AND manage your other risk factors.
2/3
One of the many reasons that your Cardiometabolic Risk Assessment includes ApoB and personalized threshold goals to get your ApoB below to reduce your risk for heart attack or stroke.
The steps:
1/3
One of the great health communicators over on the 🐦 site is Dr. Gil Carvalho; I hope he starts posting here soon.
His most recent video breaks down several of the conspiracy myths about “High cholesterol is healthy!”
It's about 10 minutes; well worth your time.
www.youtube.com/watch?v=n4h1...
The greatest epedemic facing our population, and agruable our economy, is cardiometabolic disease.
Tackling cardiometabolic disease required a precision, personalized approach that goes beyond just biomarkers & also considers all personalize risk factors.
www.sciencedirect.com/science/arti...
We were recently revisiting Dr. Cromwell's terrific conversation with Dr. Gil Carvalho.
Here's a quick snippet to whet your appetite.
As discussed throughout the interview, the old paradigm of "lower cholesterol" isn't enough to complete the conversation.
Full 📹: youtu.be/IwzNnUhqUzc
For 2024, we wish you a Healthy and Happy New Year!
Do differences in LDL particle size, e.g. “large-fluffy” vs. “small-dense” or particle number better indicate cardiovascular disease risk?
Watch the full 15-minute segment here here:
youtu.be/kplh30RmYo8
Lipoprotein(a) or Lp(a) is a significant risk factor for cardiovascular disease, but is severely undertested. ~20% of people have this genetic risk factor.
We’ve made Lp(a) screening available for just $24 to maximize access to this important biomarker.
precisionhealthreports.com/lpa